TY - JOUR
T1 - Biliopancreatic diversion
T2 - long-term effects on gonadal function in severely obese men
AU - Alagna, Sergio
AU - Cossu, Maria L.
AU - Gallo, Paola
AU - Tilocca, Pier L.
AU - Pileri, Piera
AU - Alagna, Giuliano
AU - Maninchedda, Paola
AU - Sini, Annalisa L.
AU - Pilo, Luca
AU - Rovasio, Pier P.
AU - Noya, Giuseppe
AU - Masala, Antonia
PY - 2006/3
Y1 - 2006/3
N2 - Background: This study investigated hormonal parameters of gonadal function in severely obese men before and 1 year after undergoing biliopancreatic diversion (BPD). Methods: This observational 1-year postoperative study conducted at medical and surgical clinics at an academic medical center in Italy followed 20 severely obese men age 21 to 63 years, with a mean (± standard deviation) body mass index (BMI) of 47.3 ± 13.1. The following parameters were evaluated: body composition, using body impedance analysis (BIA), and serum levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), total testosterone, estradiol 17β, and leptin. Results: At a mean 12 ± 1 months after surgery, the patients showed a significant decrease in weight, from 132.1 ± 36.9 before surgery to 93.5 ± 20 kg (P <.0001), and BMI, from 47.3 ± 13.1 before surgery to 33.5 ± 7 (P <.0001). LH increased from 2.42 ± 1.59 to 4.97 ± 2.6 mIU/ml (P <.0001), FSH increased from 2.85 ± 1.85 to 4.9 ± 4.2 mIU/mL (P = .021), and total testosterone increased from subnormal presurgical values to within normal range (2.81 ± 1.08 to 9.12 ± 1.37 ng/mL; P <.0001), whereas estradiol 17β decreased from elevated basal levels of 44.0 ± 29 to 16.7 ± 6.9 pg/mL (P <.0001). The basal leptin level dropped from 33.0 ± 9.23 to 16.6 ± 5.12 ng/mL (P <.0001), reflecting the decrease in body fat. Subjective improvement in sexual performance was reported by 80% of patients. Conclusions: Severe obesity is coupled with some significant alterations of the gonadotropin-testicular axis and estradiol 17β and leptin blood levels. These derangements were substantially corrected by 1 year after BPD. © 2006 American Society for Bariatric Surgery.
AB - Background: This study investigated hormonal parameters of gonadal function in severely obese men before and 1 year after undergoing biliopancreatic diversion (BPD). Methods: This observational 1-year postoperative study conducted at medical and surgical clinics at an academic medical center in Italy followed 20 severely obese men age 21 to 63 years, with a mean (± standard deviation) body mass index (BMI) of 47.3 ± 13.1. The following parameters were evaluated: body composition, using body impedance analysis (BIA), and serum levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), total testosterone, estradiol 17β, and leptin. Results: At a mean 12 ± 1 months after surgery, the patients showed a significant decrease in weight, from 132.1 ± 36.9 before surgery to 93.5 ± 20 kg (P <.0001), and BMI, from 47.3 ± 13.1 before surgery to 33.5 ± 7 (P <.0001). LH increased from 2.42 ± 1.59 to 4.97 ± 2.6 mIU/ml (P <.0001), FSH increased from 2.85 ± 1.85 to 4.9 ± 4.2 mIU/mL (P = .021), and total testosterone increased from subnormal presurgical values to within normal range (2.81 ± 1.08 to 9.12 ± 1.37 ng/mL; P <.0001), whereas estradiol 17β decreased from elevated basal levels of 44.0 ± 29 to 16.7 ± 6.9 pg/mL (P <.0001). The basal leptin level dropped from 33.0 ± 9.23 to 16.6 ± 5.12 ng/mL (P <.0001), reflecting the decrease in body fat. Subjective improvement in sexual performance was reported by 80% of patients. Conclusions: Severe obesity is coupled with some significant alterations of the gonadotropin-testicular axis and estradiol 17β and leptin blood levels. These derangements were substantially corrected by 1 year after BPD. © 2006 American Society for Bariatric Surgery.
KW - Biliopancreatic diversion
KW - Estradiol 17β
KW - Gonadotropins
KW - Leptin
KW - Testosterone
UR - http://www.scopus.com/inward/record.url?scp=33645921945&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645921945&partnerID=8YFLogxK
U2 - 10.1016/j.soard.2006.01.005
DO - 10.1016/j.soard.2006.01.005
M3 - Article
C2 - 16925327
AN - SCOPUS:33645921945
VL - 2
SP - 82
EP - 86
JO - Surgery for Obesity and Related Diseases
JF - Surgery for Obesity and Related Diseases
SN - 1550-7289
IS - 2
ER -